Harshbarger Benjamin

CIK 00016531333 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001653133

Recent Transactions

50 trades

Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−262,500→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−55,000→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−33,333→ 0 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2025-03-21+262,500→ 262,500 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2024-02-08+175,000→ 175,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2023-06-02+90,000→ 90,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2022-03-01+55,000→ 55,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2021-06-08+200,000→ 200,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2021-06-02+400,000→ 400,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2020-06-11+45,000→ 45,000 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Stock
2019-05-09$1.22/sh−212→ 3,683 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Stock
2018-09-17$3.94/sh−98→ 3,895 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Stock
2018-05-15$4.15/sh−150→ 3,993 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Stock
2018-05-09$4.26/sh−322→ 4,143 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Stock
2018-04-01$3.50/sh−52→ 4,465 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2018-02-12+45,000→ 45,000 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2017-10-06+75,000→ 75,000 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2017-09-17−337→ 336 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Shares
2017-09-17$7.08/sh−109→ 1,673 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common Shares
2017-09-17+337→ 1,782 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Shares
2017-05-15$8.97/sh−232→ 1,445 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2017-05-15−717→ 0 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common Shares
2017-05-15+717→ 1,677 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common Shares
2017-05-09+349→ 819 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common Shares
2017-05-09+375→ 1,081 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Shares
2017-05-09$9.42/sh−121→ 960 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2017-05-09−375→ 1,122 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2017-05-09−349→ 697 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Shares
2017-05-09$9.42/sh−113→ 706 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Common Shares
2017-04-01+178→ 527 total
Tax Payment
NOVELION THERAPEUTICS INC.
Common Shares
2017-04-01$10.74/sh−57→ 470 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2017-04-01−178→ 177 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (right to buy)
2016-12-22+97,400→ 97,400 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2016-11-29−1,733→ 0 total
Award
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2016-11-29+3,589→ 3,589 total
Award
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2016-11-29+2,564→ 2,564 total
Award
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2016-11-29+7,486→ 7,486 total
Award
NOVELION THERAPEUTICS INC.
Common Shares, without par value
2016-11-29+1,747→ 1,747 total
Award
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2016-11-29+3,366→ 3,366 total
Award
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2016-11-29+5,230→ 5,230 total
Award
NOVELION THERAPEUTICS INC.
Restricted Stock Units
2016-11-29+1,777→ 1,777 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-11-29−1,817→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-11-29−3,399→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2016-11-29−3,282→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2016-11-29−7,300→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-11-29−10,683→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2016-11-29−3,500→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2016-11-29−2,500→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2016-11-29−5,100→ 0 total
Disposition to Issuer
Aegerion Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-11-29−25,529→ 0 total

Companies

Recent Filings

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210

View on SEC.gov